Knockdown of SLC41A1 Magnesium Transporter Promotes Mineralization and Attenuates Magnesium Inhibition During Osteogenesis of Mesenchymal Stromal Cells

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2017 Feb 23

PMID 28222767

Citations 14

Authors

Yu-Tzu Tsao

Ya-Yi Shih

Yu-An Liu

Yi-Shiuan Liu

Oscar K Lee

Affiliations

Soon will be listed here.

Abstract

Background: Magnesium is essential for numerous physiological functions. Magnesium exists mostly in bone and the amount is dynamically regulated by skeletal remodeling. Accelerating bone mass loss occurs when magnesium intake is insufficient; whereas high magnesium could lead to mineralization defects. However, the underlying magnesium regulatory mechanisms remain elusive. In the present study, we investigated the effects of high extracellular magnesium concentration on osteogenic differentiation of mesenchymal stromal/stem cells (MSCs) and the role of magnesium transporter SLC41A1 in the mineralization process.

Methods: Murine MSCs derived from the bone marrow of BALB/c mouse or commercially purchased human MSCs were treated with osteogenic induction medium containing 5.8 mM magnesium chloride and the osteogenic differentiation efficiency was compared with that of MSCs in normal differentiation medium containing 0.8 mM magnesium chloride by cell morphology, gene expression profile of osteogenic markers, and Alizarin Red staining. Slc41a1 gene knockdown in MSCs was performed by siRNA transfection using Lipofectamine RNAiMAX, and the differentiation efficiency of siRNA-treated MSCs was also assessed.

Results: High concentration of extracellular magnesium ion inhibited mineralization during osteogenic differentiation of MSCs. Early osteogenic marker genes including osterix, alkaline phosphatase, and type I collagen were significantly downregulated in MSCs under high concentration of magnesium, whereas late marker genes such as osteopontin, osteocalcin, and bone morphogenetic protein 2 were upregulated with statistical significance compared with those in normal differentiation medium containing 0.8 mM magnesium. siRNA treatment targeting SLC41A1 magnesium transporter, a member of the solute carrier family with a predominant Mg efflux system, accelerated the mineralization process and ameliorated the inhibition of mineralization caused by high concentration of magnesium. High concentration of magnesium significantly upregulated Dkk1 gene expression and the upregulation was attenuated after the Slc41a1 gene was knocked down. Immunofluorescent staining showed that Slc41a1 gene knockdown promoted the translocation of phosphorylated β-catenin into nuclei. In addition, secreted MGP protein was elevated after Slc41a1 was knocked down.

Conclusions: High concentration of extracellular magnesium modulates gene expression of MSCs during osteogenic differentiation and inhibits the mineralization process. Additionally, we identified magnesium transporter SLC41A1 that regulates the interaction of magnesium and MSCs during osteogenic differentiation. Wnt signaling is suggested to be involved in SLC41A1-mediated regulation. Tissue-specific SLC41A1 could be a potential treatment for bone mass loss; in addition, caution should be taken regarding the role of magnesium in osteoporosis and the design of magnesium alloys for implantation.

Citing Articles

Strategies for promoting neurovascularization in bone regeneration.

Li X, Zhao Y, Miao L, An Y, Wu F, Han J Mil Med Res. 2025; 12(1):9.

PMID: 40025573 PMC: 11874146. DOI: 10.1186/s40779-025-00596-1.

Analysis of the CPZ/Wnt4 osteogenic pathway for high-bonding-strength composite-coated magnesium scaffolds through transcriptomics.

Shi Z, Yang F, Du T, Pang Q, Liu C, Hu Y Mater Today Bio. 2024; 28:101234.

PMID: 39309165 PMC: 11414715. DOI: 10.1016/j.mtbio.2024.101234.

Sol-gel synthesis of magnesium oxide nanoparticles and their evaluation as a therapeutic agent for the treatment of osteoarthritis.

Mei S, Jiang F, Liu N, Feng Z, Zheng Y, Yang W Nanomedicine (Lond). 2024; 19(23):1867-1878.

PMID: 39109508 PMC: 11457622. DOI: 10.1080/17435889.2024.2382421.

AMPK/mTOR Pathway Is Involved in Autophagy Induced by Magnesium-Incorporated TiO Surface to Promote BMSC Osteogenic Differentiation.

Wang G, Luo J, Qiao Y, Zhang D, Liu Y, Zhang W J Funct Biomater. 2022; 13(4).

PMID: 36412862 PMC: 9680369. DOI: 10.3390/jfb13040221.

Applications of Biodegradable Magnesium-Based Materials in Reconstructive Oral and Maxillofacial Surgery: A Review.

Vujovic S, Desnica J, Stanisic D, Ognjanovic I, Stevanovic M, Rosic G Molecules. 2022; 27(17).

PMID: 36080296 PMC: 9457564. DOI: 10.3390/molecules27175529.

References

Romani A . Cellular magnesium homeostasis. Arch Biochem Biophys. 2011; 512(1):1-23. PMC: 3133480. DOI: 10.1016/j.abb.2011.05.010. View

Schweigel-Rontgen M, Kolisek M . SLC41 transporters--molecular identification and functional role. Curr Top Membr. 2014; 73:383-410. DOI: 10.1016/B978-0-12-800223-0.00011-6. View

Hussain A, Bessho K, Takahashi K, Tabata Y . Magnesium calcium phosphate as a novel component enhances mechanical/physical properties of gelatin scaffold and osteogenic differentiation of bone marrow mesenchymal stem cells. Tissue Eng Part A. 2011; 18(7-8):768-74. DOI: 10.1089/ten.TEA.2011.0310. View

Sun C, Yuan H, Wang L, Wei X, Williams L, Krebsbach P . FAK Promotes Osteoblast Progenitor Cell Proliferation and Differentiation by Enhancing Wnt Signaling. J Bone Miner Res. 2016; 31(12):2227-2238. PMC: 5642940. DOI: 10.1002/jbmr.2908. View

Quamme G . Molecular identification of ancient and modern mammalian magnesium transporters. Am J Physiol Cell Physiol. 2009; 298(3):C407-29. DOI: 10.1152/ajpcell.00124.2009. View

Lee O, Kuo T, Chen W, Lee K, Hsieh S, Chen T . Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood. 2003; 103(5):1669-75. DOI: 10.1182/blood-2003-05-1670. View

Cong Q, Jia H, Biswas S, Li P, Qiu S, Deng Q . p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. Stem Cell Reports. 2016; 6(4):566-578. PMC: 4834033. DOI: 10.1016/j.stemcr.2016.02.001. View

Zhang L, Yang C, Li J, Zhu Y, Zhang X . High extracellular magnesium inhibits mineralized matrix deposition and modulates intracellular calcium signaling in human bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun. 2014; 450(4):1390-5. DOI: 10.1016/j.bbrc.2014.07.004. View

Sims N, Martin T . Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. Bonekey Rep. 2014; 3:481. PMC: 3899560. DOI: 10.1038/bonekey.2013.215. View

10.

Nakatani S, Mano H, Ryanghyok I, Shimizu J, Wada M . Excess magnesium inhibits excess calcium-induced matrix-mineralization and production of matrix gla protein (MGP) by ATDC5 cells. Biochem Biophys Res Commun. 2006; 348(3):1157-62. DOI: 10.1016/j.bbrc.2006.07.180. View

11.

Langenbach F, Handschel J . Effects of dexamethasone, ascorbic acid and β-glycerophosphate on the osteogenic differentiation of stem cells in vitro. Stem Cell Res Ther. 2013; 4(5):117. PMC: 3854789. DOI: 10.1186/scrt328. View

12.

Jahnen-Dechent W, Ketteler M . Magnesium basics. Clin Kidney J. 2015; 5(Suppl 1):i3-i14. PMC: 4455825. DOI: 10.1093/ndtplus/sfr163. View

13.

Baker N, Sohn J, Tuan R . Promotion of human mesenchymal stem cell osteogenesis by PI3-kinase/Akt signaling, and the influence of caveolin-1/cholesterol homeostasis. Stem Cell Res Ther. 2015; 6:238. PMC: 4667507. DOI: 10.1186/s13287-015-0225-8. View

14.

Roy M, Nishimoto S . Matrix Gla protein binding to hydroxyapatite is dependent on the ionic environment: calcium enhances binding affinity but phosphate and magnesium decrease affinity. Bone. 2002; 31(2):296-302. DOI: 10.1016/s8756-3282(02)00821-9. View

15.

Feyerabend F, Witte F, Kammal M, Willumeit R . Unphysiologically high magnesium concentrations support chondrocyte proliferation and redifferentiation. Tissue Eng. 2007; 12(12):3545-56. DOI: 10.1089/ten.2006.12.3545. View

16.

MEEMA H, Oreopoulos D, Rapoport A . Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int. 1987; 32(3):388-94. DOI: 10.1038/ki.1987.222. View

17.

Bohl C, Volpe S . Magnesium and exercise. Crit Rev Food Sci Nutr. 2002; 42(6):533-63. DOI: 10.1080/20024091054247. View

18.

Liu Y, Liu Y, Huang C, Yen M, Tseng C, Chien S . Mechanosensitive TRPM7 mediates shear stress and modulates osteogenic differentiation of mesenchymal stromal cells through Osterix pathway. Sci Rep. 2015; 5:16522. PMC: 4642269. DOI: 10.1038/srep16522. View

19.

Staiger M, Pietak A, Huadmai J, Dias G . Magnesium and its alloys as orthopedic biomaterials: a review. Biomaterials. 2005; 27(9):1728-34. DOI: 10.1016/j.biomaterials.2005.10.003. View

20.

Jiang Y, Jahagirdar B, Reinhardt R, Schwartz R, Keene C, Ortiz-Gonzalez X . Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418(6893):41-9. DOI: 10.1038/nature00870. View